Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00381225

Enrollment

Registered

2006-09-27

Start date

2006-11-30

Completion date

2008-03-18

Last updated

2017-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasia

Keywords

Radio-frequency ablation; Head and Neck neoplasia.

Brief summary

To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the management of head and neck neoplasia.

Detailed description

The study evaluates the feasibility of radio-frequency ablation in the management of head and neck neoplasia.

Interventions

PROCEDUREUltra-sound guided radio-frequency ablation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with head and neck neoplasia.

Exclusion criteria

* When the patient does not meet the inclusion criteria. * When the patient has a contra-indication of surgery or anesthesia. * If the patient refuses involvement in the study.

Design outcomes

Primary

Measure	Time frame	Description
Technical success	Length of the procedure, up to 1 hour	Technical success is defined as the ability to successfully enter the thyroid nodule via ultrasound guidance and apply the RFA. Assessed via surgeon self report

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026